@article{ATM29285,
author = {Olga Vornicova and Gil Bar-Sela},
title = {Do we have a “game changer” in treating patients with brain metastasis from renal cell carcinoma?},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 8},
year = {2019},
keywords = {},
abstract = {Renal cell carcinoma (RCC) is the most common type of kidney cancer. About 25% of patients are diagnosed with metastatic disease at presentation and another 25–30% diagnosed with localized disease will develop metastasis over time (1). The incidence of brain metastasis (BM) ranged from 3–17% in various studies.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/29285}
}